Showing results (51-60 of 5,280) with videos related to

Sort By:
Pageof 528
Current Medicinal Chemistry|April 16, 2023
Futibatinib: A Potent and Irreversible Inhibitor of Fibroblast Growth Factor Receptors for Treatment of the Bile Duct CancerSurya K De
Current Medicinal Chemistry|May 5, 2023
Recent Discovery of Peptidomimetics for the Treatment of Coronavirus (COVID-19), Human Coronavirus, and EnterovirusesSurya K De
Current Medicinal Chemistry|May 1, 2023
Mitapivat: A Novel Treatment of Hemolytic Anemia in Adults with Pyruvate Kinase DeficiencySurya K De
Current Medicinal Chemistry|May 22, 2023
Discovery of Novel Cysteine Protease Inhibitors for the Treatment of Coronavirus (COVID-19)Surya K De
Current Medicinal Chemistry|February 21, 2023
Oteseconazole: First Approved Orally Bioavailable and Selective CYP51 Inhibitor for the Treatment of Patients with Recurrent Vulvovaginal CandidiasisSurya K De
Anti-Cancer Agents in Medicinal Chemistry|March 24, 2023
First Approval of Pacritinib as a Selective Janus Associated Kinase-2 Inhibitor for the Treatment of Patients with MyelofibrosisSurya K De
Recent Patents on Anti-Cancer Drug Discovery|February 28, 2023
New 1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-2-phenylisoquinoline-1(2H)-ones as Phosphoinositide 3-kinase Inhibitors for Treating Cancer and Other DiseasesSurya K De
Social Science & Medicine (1982)|January 1, 1988
Mortality in children among the Aymara Indians of southern PeruK de Meer
Anti-Cancer Agents in Medicinal Chemistry|December 5, 2024
Capivasertib: First Approved AKT inhibitor for the Treatment of Patients with Breast CancerSurya K De
Current Medicinal Chemistry|July 26, 2023
Novel Pyrazino[2,3-b] Pyrazines as mTOR Kinase Inhibitors for Treating Cancer and other DiseasesSurya K De
Pageof 528